In fact, venture capitalists have increased investment in generative AI by 425% since 2020 to $2.1 billion. In the life sciences industry in particular, leading pharma companies are already ...
Maniar describes how Bayer, one of the world’s largest pharmaceutical companies, is leveraging Gen AI to overcome the very specific challenge of working with limited data sets; the company is ...
GEN: At BioFuture, you were part of a panel discussing AI in the pharmaceutical industry. Let’s talk about where AI is currently being used more broadly. AI has been around for more than 10 years.
Marketing-wise, Raeymaeckers said gen AI in the next couple of years may help his and other pharma companies finally succeed in turning omnichannel marketing from a “push” to a “pull ...
Developers can now turn to generative artificial intelligence (Gen AI) to code faster and more efficiently, but they should do so with caution and no less attention than before. While the use of ...
Paris, November 19, 2024 – The Capgemini Research Institute’s new report, “New defenses, new threats: What AI and Gen AI bring to cybersecurity”, published today, suggests that while new ...
Gen AI introduces three major risk areas for organizations ... high-tech; industrial equipment manufacturing; pharma and healthcare and public sector. Capgemini is a global business and technology ...